Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Amphion Innovations LSE:AMP London Ordinary Share GB00B0DJNP99 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 0.525p 0.50p 0.55p 0.525p 0.525p 0.525p 218,181 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 0.1 -13.6 -7.3 - 1.10

Amphion Share Discussion Threads

Showing 2126 to 2149 of 2150 messages
Chat Pages: 86  85  84  83  82  81  80  79  78  77  76  75  Older
DateSubjectAuthorDiscuss
22/8/2018
06:45
That 'book value' was confusing me, still is, and is an accounting term which I think represents the total value AMP shares would be worth should Motif be liquidated. In fact our shares are worth considerably more in the market. We retain 8.51% with 24,475,591 shares. These if sold @33.5p as today's were would bring in £8.2m or $10.6m. So we are well able to cover the loan Facility outstanding if we have to keep selling. As discussed previously, don't think this is the end of Amp's debts, far from it. Someone on MTFB LSE BB stated he thought AMP's selling and 'overhang' were having considerable drag on the MTFB share price Maybe that is so, in which case we are doing ourselves out of deserved money payback from a company with considerable prospects. Not sure of this effect myself because we state we are selling directly to an Institutional Investor each time, who can't be dumping them as they'd often be at a loss.
2pablo
21/8/2018
20:30
from the recent broker note: Net proceeds of approximately US$1,273,000 from the sale of these Motif shares are to be used as partial repayment of Amphion’s loan facility originally announced on 5 June 2014 (with the most recent terms being detailed on 22 December 2017), as well as ongoing business operations and development of Amphion's other Partner Companies. Following this sale, Amphion's holding will represent 8.51% of the issued share capital of Motif. The Motif shares sold had a book value of US$1,339,166 as at 30 June 2018. Following repayment, the loan balance of the Facility will be US$2,822,642 including fees and accrued interest. The remaining loan balance is expected to be repaid in 3 monthly installments from 15 October - 15 December 2018.
euclid5
15/8/2018
19:11
Https://uk-investor.com/2018/08/15/is-now-the-time-to-buy-motif-bio-plc-lon-mtfb-after-the-fdas-acceptance-of-iclaprims-new-drug-application/
spmc
14/8/2018
20:09
For this degree of performance , i would expect them to pay compensation to amphion. A woeful performance. Mistake after mistake made by the solicitors acting for datatern, and this coterie let them off scot free.
escapetohome
14/8/2018
20:02
hoggar - Indeed : In May 2017, Richard Morgan and Robert Bertoldi, Directors of the Company, entered into a deed of postponement where they have agreed to postpone the repayment of the amounts owed to them, which total US $4,300,000, until all other debts of the company are repaid. With regards salaries, Morgan gets $350k and Bertoli £300k but both have deferred about 30%. Big salaries for not a lot of progress. (Jun '18 - Final Results)
2pablo
14/8/2018
18:11
My notes on this company suggest Morgan and Bertoldi are owed over $4million for fees and salaries. This dates back to the beginning of the year. I would guess the exorbitant fees these fat cats pay themselves will now exceed $5mil. However Morgan must be feeling some sense of guilt and embarrassment because he and Bertoldi are delaying accepting this money until all other debt is paid. One wonders if this was the cause of Bertoldi's swan song? I can hear all investors moaning as to why these fat cats should be paid one cent considering the board members financial ineptitude. Well, they are guaranteed tapered fees dependent on performance. But that performance only relates to IPO success of partner companies and a few directorship bolt ons. unfortunately, this one sided business model does not reward the small investor unless liquidity remains in the stock.
hoggar
14/8/2018
16:28
Datatern had the legal case thrown out because we couldn't afford the legal team - case to be resumed if we ever have the wherewithal. sorksandnorks : Loan currently stands at $6,187,786. Convertible promissory note is for £6m. This latter is due to be converted to shares @ 3p on 31st December 2018, so no debt there. Elsewhere : "Most of the remaining loans on the balance sheet are due to the Estate of Jim Macaleer, our former Chairman, and the Estate has agreed in principle to extend payment to 31 December 2018. As a result, all of our major categories of loans have been extended to December 2018." This is Robert Bertoldi's email : RBertoldi@amphionplc.com Bob Bertoldi President & Chief Financial Officer I'm pretty sure that will get him and he can easily spell out how much debt we have and he also spelled out to me a few years ago what we held in Motif which might well be worth confirming.
2pablo
14/8/2018
11:49
What happened to Datatern to be listed as a wipeout ? Not followed this for a while. Liabilities from memory were over 20 million, not a impossible situation if Motif trades again at 60p+
dave4545
14/8/2018
11:43
Good to see some views on AMP being aired. From the AMP website, it appears that AMP has holdings in the following companies. They are listed showing the % held by AMP and my estimate of their values - I have been very strict with these and some of those marked "nil value" may very well be worth something but I am considering the worst case scenario. Access - 15.07% - nil value Firestar - 11.86% - nil value Polarean - 24.0% - today's market cap = £11.7m, hence AMP's share = £2.8m MotifBio - 9.5% - today's market cap = £102.3m, hence AMP's share = £9.7m Private Markets - 25.33% - nil value Wellgen - 24.34% - nil value Datatern - 100% - nil value From this, AMP's market cap today should be £2.8m + £9.7m = £12.5m. But, on ADVFN this morning, AMP's market cap = £1.7m and AMP's mid share price = 0.8p. So, ignoring any debt, AMP's mid share price should be (12.5/1.7) x 0.8 = 5.88p. The problem, of course, is the debt and I do not know how much that is. If anyone does can they please post it on this board so that I can work out what I think the mid share price should be. Many thanks.
sorksandnorks
14/8/2018
09:36
Used to be great for spikes this one when Mtfb was doing well so even though the valuation does not match the liabilities there is still a chance of a spike when Mtfb is on the move so worth watching especially as price is at all time low I believe.
dave4545
14/8/2018
08:52
Not a flicker on the news from mtfb today.... interesting.
rizler
12/8/2018
13:34
I wouldnt trust the managent one iota. I mean that. They could have made huge success, they lacked the acumen to do so. The City - i address you - do not waste further investment in this ‘ outfit ‘
escapetohome
12/8/2018
11:51
Amp will respond as if on steroids! Not too sure about that statement. This company is so heavily in debt its total assets will not cover due payment in time. As I have posted many times over the years on this post, Morgan needs to incorporate a new business strategy. It would appear he has finally realised this fact and gone away to draw up a new business model for Amphion and save his considerable investment. Time is his enemy at the moment and the stagnant performance of current investments will not pay the monthly instalments or indeed the end of year repayments. Another restructuring is in the offering if the loan bearers want their money on time. The trouble is, Morgan’s curriculum vitae is quite frankly pathetic. His new business plan involves assisting late stage IPO businesses with advising and collecting financial investment support. Now where have we heard that before!!! That might be a nice little earner for him with the exorbitant fees he and his team will no doubt demand, but what does the investor get, debt and more debt suppressing the stock. In the fifteen years since Amphion listed he has managed the company down to junk status. Spending tens of millions of investor’s money on American patent lawyers chasing the likes of Microsoft and SAF for infringements was like the David and Goliath fairy tale. The current situation is quite dismal indeed. With only a 9.5% holding in Motif it is almost certain the next to go will be its holding in Polarean to fend off the sharks. Even if Motif suddenly gained full approval the current mounting debt will dilute and hold back the share price A better scenario would be a large Bio company buy out. This might be what Morgan and Amphion are hoping for in the coming months.
hoggar
10/8/2018
14:12
Look at it as very cheap option on MTFB. Currently MTFB is unloved. In spite of all the relative positive news re P3 and NDA progress its shares still languish around 30p. If /when the bounce occurs with MTFB then AMP will respond as if on steroids!
dlm2602
10/8/2018
13:28
Does anyone care about AMP anymore? The silence on this board is deafening. We all know that it is all but dead but can't we at least have a dead cat bounce?
sorksandnorks
10/8/2018
13:28
... but perhaps the cat is still falling!
sorksandnorks
05/7/2018
21:08
Headed for 0.5p i would say.
escapetohome
05/7/2018
12:22
MTFB up 5% and this down 10%... I thought this was a warrant on MTFB..
pjj71
07/6/2018
12:34
Another speeding ticket is coming my way in due course :(
speeding granny
23/5/2018
17:19
MTFB holders should pause a while IMV.
ohisay
23/5/2018
16:35
I think now we know why the two directors suddenly vanished??? Morgan has run this company into the ground. I cannot think of any other viable assets this company can sell to stay afloat. So far this inept man has flogged off all tangible assets in all partner companies including selling Motif and kromek shares at list price. So what is left for the remaining investors here??? Not much I'm afraid. Even the remaining 10% stock Amp have in motif will not pay off the debts owed at current prices. Morgan owes investors a full explanation as to the direction ( if any )this company is going and how he intends to finance the operating costs and still raise finance for the remaining companies. The company prospectus has lead investors to believe each and all partner companies will be be worth 100mil to AMP investors??? The last sentence says it all folks.
hoggar
17/5/2018
10:01
so our share of mtfb will be reduced a little with the book building fund raising at mtfb, but it was something we were prepared for still a big investor here due to my belief in the future of mtfb, approval of Iclaprim and revaluation of mtfb soon, I think the fund raising provides more funds to mtfb to develop so has to be a good thing
gclark
20/4/2018
15:30
But this company has two significant marketable assets in traded companies, yes, and also debt, but if you believe in those companies ...
gclark
20/4/2018
08:01
My thought on today's RNS after hearing Richard Morgan's words, "We believe that as our companies' progress, Amphion's shareholders will benefit in turn" was simply WHEN? Been a very long road here and I, like you, gclark, thought AMP was a very good vehicle but, of course, mgmt looks after itself first. They've got a lot more invested here than we have and a lot more at stake. Are they back taking decent salaries again or have they still forsaken them for want of trying to save the company? No point of selling at these levels even if I could (Beaufort!) so it's a Hold from me
2pablo
Chat Pages: 86  85  84  83  82  81  80  79  78  77  76  75  Older
Your Recent History
LSE
AMP
Amphion
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181209 19:47:39